Collaboration aims to enable discovery of first-in-class therapeutic candidates NEW YORK & SHANGHAI — Schrödinger, Inc. (Nasdaq: SDGR) and Viva Biotech Holdings (1873.HK) today announced a strategic collaboration to expand the reach of structure-based drug discovery by generating de novo crystal structures of high-value targets. Under the terms of the collaboration, Schrödinger will identify drug discovery […]

CAMBRIDGE, UK and Durham, NC, USA: Optibrium™, a leading provider of software and services for drug discovery, and the North Carolina School of Science and Mathematics (NCSSM), the states leading high school for science, technology and math education, are celebrating five years of an education support collaboration. As part of this specialist science and technology summer school […]

Toronto, Canada —ACD/Labs, an informatics company that develops and commercializes software in support of R&D, today announced that ACD/ChemSketch Freeware has been downloaded by over two million users worldwide. This free version of ChemSketch, intended for academic and personal use, has been accessible for more than two decades to students, academics, and scientists to communicate research and […]

Discngine is excited to announce a partnership with LabVoice. The partnership will focus on supporting the presence of voice assistants built for the laboratory and continue a shared vision of creating a more efficient, more compliant, and safer lab through the power of voice. With technology playing an increasingly critical role in every aspect of […]

NEW YORK–Schrödinger (Nasdaq: SDGR), whose physics-based software platform enables discovery of high-quality, novel molecules for therapeutics and materials, today announced the appointments of Jeffrey A. Chodakewitz, M.D., and Gary Ginsberg to its Board of Directors. Dr. Chodakewitz is a veteran in the biopharmaceutical industry who previously held leadership roles at Vertex Pharmaceuticals and Merck & […]

The hosted informatics platform will facilitate the advancement of Standigm’s collaborative drug discovery projects SEOUL, South Korea and SAN FRANCISCO — Originally published here: https://www.collaborativedrug.com/standigm-selects-cdd-vault-augment-drug-discovery-ai-technology Standigm (Seoul, South Korea), a company using artificial intelligence (AI) technology for drug discovery and development announced today that it has selected the CDD Vault platform from Collaborative Drug Discovery (San Francisco, USA) to complement its […]

Columbus, Ohio —The Ohio State University College of Pharmacy Division of Medicinal Chemistry and Pharmacognosy and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) recently partnered to build a shared resource focused on phenotypic and target-based screening of libraries of small molecules via high-content and […]

High performance libraries provide strong foundation for new developments to StarDrop drug discovery software. CAMBRIDGE, UK and SANTA FE, NEW MEXICO, USA – Optibrium™ and OpenEye Scientific (OpenEye), leading providers of software and services for drug discovery, today announced that StarDrop™, Optibrium’s software for small molecule design, optimisation and data analysis, is now powered by OpenEye […]

3decision® will enable Sosei Heptares to combine public and proprietary structural data and derive unique GPCR structural insights. Discngine, a software company specializing in developing applications for life sciences research, announces today that Sosei Heptares, an international biopharmaceutical group focused on G protein-coupled receptors (GPCRs), has selected its 3decision® software to be part of an […]

StarDrop™ and Augmented Chemistry™ prove a powerful combination in AI-guided design and validation of novel antimalarial drug candidates In silico designed compound demonstrates potency against pfATP4 protein target in malaria parasite CAMBRIDGE, UK  – Optibrium™, leading providers of software and services for drug discovery, and Intellegens™, a spin-out from the University of Cambridge with a […]